ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,548Medicare Part D Prescriptions Filled, Including Refills

Rank: 212 out of 692

$721K Total Retail Price of All Prescriptions

Rank: 170 out of 692

489 Patients Receiving at Least One Drug in Part D
40% Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Louisiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 489 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

43% of this provider’s 489 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 818 303 204 S3 1 3
AMLODIPINE BESYLATE 500 277 110 2 1
FUROSEMIDE 332 202 80 3 7
MELOXICAM 311 117 130 4 24
LISINOPRIL 298 145 75 5 4
ZOLPIDEM TARTRATE 250 74 69 6 25
METFORMIN HCL 205 88 50 7 9
LEVOTHYROXINE SODIUM 201 109 33 8 2
TRAMADOL HCL 197 71 89 9 20
CARVEDILOL 197 107 55 9 21
OMEPRAZOLE 195 116 46 11 8
NEXIUM 183 34 46 12 18
CEPHALEXIN 168 48 124 13 142
POTASSIUM CHLORIDE 140 88 36 14 14
CLOPIDOGREL 140 89 23 14 17
BYSTOLIC 136 87 26 16 81
LISINOPRIL-HYDROCHLOROTHIAZIDE 133 68 37 17 38
CRESTOR 133 69 20 17 27
AZITHROMYCIN 131 51 88 19 51
GLIMEPIRIDE 131 61 24 19 30
ALPRAZOLAM 131 57 40 B 19 15
SIMVASTATIN 129 76 25 22 5
ATORVASTATIN CALCIUM 126 79 25 23 6
LEVOFLOXACIN 123 53 85 24 85
PRAVASTATIN SODIUM 121 69 26 25 10
LOSARTAN-HYDROCHLOROTHIAZIDE 116 78 32 26 45
WARFARIN SODIUM 109 52 18 27 28
GABAPENTIN 95 27 24 28 12
LANTUS SOLOSTAR 82 48 21 29 78
TRAZODONE HCL 76 14 15 30 44
FLUCONAZOLE 74 <11 31 31 147
CLONIDINE HCL 74 69* 13 31 37
BD ULTRA-FINE PEN NEEDLE 73 26 31 33 118
SERTRALINE HCL 72 31 12 34 31
METOPROLOL SUCCINATE 72 27 13 34 13
HYDRALAZINE HCL 70 35 15 36 68
METOPROLOL TARTRATE 70 41 19 36 16
VALSARTAN-HYDROCHLOROTHIAZIDE 70 28 14 36 63
LYRICA 68 32 16 39 70
DIOVAN 67 36 13 40 34
CYCLOBENZAPRINE HCL 66 <11 33 R 41 90
EXFORGE 63 33 15 42 156
ATENOLOL 62 33 13 43 22
LOSARTAN POTASSIUM 62 25 13 43 19
VOLTAREN 61 29 37 45 210
PROMETHAZINE HCL 60 21 25 R 46 89
DIAZEPAM 60 11 17 B 46 79
BUMETANIDE 59 <11 <11 48 104
TAMSULOSIN HCL 58 <11 <11 49 35
PROAIR HFA 58 22 28 49 60
AMLODIPINE BESYLATE-BENAZEPRIL 58 <11 <11 49 48
AZOR 57 <11 <11 52 248
CLOTRIMAZOLE-BETAMETHASONE 55 20 32 53 207
ALLOPURINOL 55 22 14 53 36
KLOR-CON M20 54 41 16 55 72
CELEBREX 54 23 14 55 87
LIDODERM 53 21 22 57 229
IBUPROFEN 53 <11 25 57 124
CYMBALTA 52 <11 <11 59 41
HYDROCHLOROTHIAZIDE 52 28 21 59 11
ESCITALOPRAM OXALATE 52 <11 13 59 33
ZETIA 52 <11 <11 59 83
SPIRIVA 50 25 13 63 74
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.